| Literature DB >> 23164220 |
Laura Martínez García1, Ingrid Arévalo-Rodríguez, Ivan Solà, R Brian Haynes, Per Olav Vandvik, Pablo Alonso-Coello.
Abstract
BACKGROUND: Scientific knowledge is in constant change. The flow of new information requires a frequent re-evaluation of the available research results. Clinical practice guidelines (CPGs) are not exempted from this phenomenon and need to be kept updated to maintain the validity of their recommendations. The objective of our review is to systematically identify, describe and assess strategies for monitoring and updating CPGs. STUDY DESIGN ANDEntities:
Mesh:
Year: 2012 PMID: 23164220 PMCID: PMC3520818 DOI: 10.1186/1748-5908-7-109
Source DB: PubMed Journal: Implement Sci ISSN: 1748-5908 Impact factor: 7.327
Figure 1Updating Clinical Practice Guidelines Strategies.
Figure 2Flow diagram for the identification of studies. *Ordered by type of strategy and chronology; #Main publication for the study; ‡Only abstract available; §Information provided by the author.
Characteristics of included studies*
| AHRQ (USA) | Evaluating if out of date | One strategy | 17 CPGs | Several topics | 4-8 years | |
| FNCLCC (France) | Evaluating if out of date | One strategy | 1 CPG | PET scanning in cancer | NS | |
| RTI-UNC EPC, USPSTF, AHRQ (USA) | Evaluating if out of date | Two strategies | 6 topics | Prevention topics | 6 years | |
| NCGC, NICE (UK) | Evaluating if out of date | One strategy | 1 CPG | Obesity | 3 years | |
| North of England Evidence Based Guideline Development Programme (UK) | Updating | Two strategies (development vs updating) | 2 CPGs | Angina and asthma in adults | 4-5 years | |
| AHTA (Australia) | Updating (updating by adapting) | One strategy | 1 CPG | Posttraumatic stress disorder | 1-3 years | |
| ERHCA (Italy) | Updating | Two strategies (development vs updating) | 15 recommendations | Anticancer drugs for breast, colorectal and lung cancer | 3 years | |
| CCOPGI (Canada) | Continuously monitoring and updating | One strategy | 20 CPGs | Cancer | NS |
*Ordered by type of strategy and chronology; ‡Only abstract available; §Information provided by the author.
Abbreviations: AHRQ: Agency for Healthcare Research and Quality; AHTA: Adelaide Health Technology Assessment; CCOPGI: Cancer Care Ontario Practice Guidelines Initative; CPG: Clinical practice guideline; ERHCA: Emilia-Romagna Health Care Agency; FNCLCC: Fédération Nationale des Centres de Lutte Contre le Cancer; NCGC: National Clinical Guidelines Centre for Acute and Chronic Conditions; NICE: National Institute for Health and Clinical Excellence; NS: Not stated; PET: Positron Emission Tomography; RTI-UNC EPC: RTI International–University of North Carolina Evidence-based Practice Center; UK: United Kindom; USA: United States of America; USPSTF: US Preventive Services Task Force; vs: Versus.
Stages of the strategies*
| Within specific timeframe | Identification of main recommendations | Reviewers (2) Chairs of the original CPG expert panel (15) Members related with original CPGs (2) Members of the original CPG expert panel (121) Nonpanel experts (8) | Reviewed references (title, abstract and articles) Reviewed the relevance of selected references Based on new evidence and judgment guidelines were classified in to: major update, minor update or still valid | NA | NA | ||
| Monitoring | Discussion about priority of topics to be updated | Methodologist (NS) Original working group (NS) | Selection of references Evaluation the impact of reference on existing guideline: consistent with existing guidelines, inconsistent or concern new topics | NA | NA | ||
| Within specific timeframe | Developed analytic framework, critical key questions and eligibility criteria Survey to national/ international experts | Clinicians (4) Health services researchers (2) Reviewers (4) Librarians (NS) National or international experts (13) | Assessed the relevance of abstracts, full-text articles and original studies Used of update memos with studies that judged as eligible and addressed a critical key question | NA | NA | ||
| Within specific timeframe | NS | Methodologist (3) Clinicians (3) | Selection and assessment guidelines with AGREE Narrative summary of the methodological aspects and major findings of each guideline | NA | NA | ||
| Within specific timeframe | NS | General practitioners (8) Consultants (2) Nurses (2) Health economists (2) Guideline methodologist (2) | Systematic review Evidence tables or text summaries | 3 situations: new recommendations; refinement recommendations; and unchanged recommendations | NS | ||
| NS | Additional research questions | Methodologist (9) Clinicians (6) | Verification of results and study quality from the original review | Integrating a qualitative and quantitative data on the prior review and developing recommendations | NS | ||
| Within specific timeframe | Mail consultation to experts from development group Relevant evidence | Coordinating group (10) 3 multidisciplinary panels (NS) External methodological group (NS) | Evidence selection Application GRADE methodology Evidence tables Informed and discussed with panellist in meetings | Classified strength of recommendation in 4 levels: strong positive, weak positive, weak negative and strong negative Voted by experts in meeting | NS | ||
| Monitoring | NS | Health information specialist (3) Lead author of the original guideline (NS) DSG who developed guideline: chair, members and research assistant (NS) | Identified potentially relevant new trials, meta-analyses an evidence-based guidelines or update results from trials included in original guideline Reviewed abstracts and articles Considered relevance of each reference to original guideline question Interpreted new evidence in the context of original guideline Descriptive and summaries of new evidence | DSG choose implications of new evidence on clinical recommendations: unchanged recommendation, strength recommendation, change recommendation | Notice linked to each guideline to keep practitioners aware that regular update search conduced Update bulletin with new evidence emerged Notice at the top of the guideline to alert practitioners that guideline was review Removed obsolete guidelines Integrated evidence update into original report (dynamic ‘living’ practice guidelines) |
*Ordered by type of strategy and chronology; ‡Only abstract available; §Information provided by the author.
Abbreviations: AIM Abridged Index Medicus, APM Agence de Presse Médicale, ASCO American Society of Clinical Oncology, CPG Clinical practice guideline, DSG Disease site group, GRADE Grading of Recommendations Assessment, Development and Evaluation, HSTAT Health Service/Technology Assessment Text, NGC National Guideline Clearinghouse, NIH National Institutes of Health, NA Not applicable, NS Not stated, RCT. Randomized controlled trials, SBU Swedish Council on Health Technology Assessment, SR Systematic review.
Results of the strategies*
| 208 articles reviewed/7150 articles initially identified (2,9) | 13/17 CPGs (76,5) | |
| 118 references submitted to the working group/261 references initially identified (45,2) | NS | |
| Modified Shekelle et al. search: 36 eligible studies/1382 citations initially identified (2,6) | NS | |
| | Exhaustive search: 45 eligible studies/3687 citations initially identified (1,2) | NS |
| 7 guidelines reviewed/25 guidelines initially identified (28) | 0/NS recommendations | |
| Angina CPG: 59 acceptable paper/5941 citations initially identified (1) | 0/NS recommendations | |
| | Asthma CPG: 79 acceptable paper/7560 citations initially identified (1) | 0/NS recommendations |
| 43 studies included/19423 citations initially identified | 11/NS questions | |
| 24 papers included/686 records initially screened (3,5) | 6/15 recommendations (40) | |
| 19 citations with impact on recommendation/80 citations initially identified (23,8) | 6/20 CPGs (30) |
*Ordered by type of strategy and chronology; ‡Only abstract available; §Information provided by the author.
Abbreviations: CPG Clinical practice guideline, NS Not stated.